These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7881194)

  • 1. Drug kinetics and drug resistance in optimal chemotherapy.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):191-209. PubMed ID: 7881194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1994; 11(1):45-59. PubMed ID: 8057040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal chemical control of populations developing drug resistance.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1992; 9(3):215-26. PubMed ID: 1295929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic treatments: a study of the interplay among drug resistance, toxicity and recuperation from side effects.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Mar; 59(2):205-32. PubMed ID: 9116600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of optimal control theory in cancer chemotherapy.
    Swan GW
    Math Biosci; 1990 Oct; 101(2):237-84. PubMed ID: 2134485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal chemotherapy regimens: influence of tumours on normal cells and several toxicity constraints.
    Matveev AS; Savkin AV
    IMA J Math Appl Med Biol; 2001 Mar; 18(1):25-40. PubMed ID: 11339336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy--theory and practice.
    Capizzi RL; Keiser LW; Sartorelli AC
    Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
    [No Abstract]   [Full Text] [Related]  

  • 11. A mathematical model of the development of drug resistance to cancer chemotherapy.
    Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of optimal drug administration strategies for cancer-chemotherapy in the framework of systems theory.
    Acharya RS; Sundareshan MK
    Int J Biomed Comput; 1984; 15(2):139-50. PubMed ID: 6724730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematic models for cancer chemotherapy: pharmacokinetic and cell kinetic considerations.
    Chuang S
    Cancer Chemother Rep; 1975; 59(4):827-42. PubMed ID: 1175173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment.
    Panetta JC
    Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo correlation in anticancer drug sensitivity test using AUC-based concentrations and collagen gel droplet-embedded culture.
    Inaba M; Tashiro T; Sato S; Ohnishi Y; Tanisaka K; Kobayashi H; Koezuka M
    Oncology; 1996; 53(3):250-7. PubMed ID: 8643230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bilinear control model for tumor growth and chemotherapy.
    Vaidya VG; Alexandro FJ; Vaidya PG
    Int J Biomed Comput; 1985 Sep; 17(2):145-54. PubMed ID: 4055120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal strategy in chemotherapy for Malthusian model of cancer growth.
    MaroĊ„ski R
    Acta Bioeng Biomech; 2017; 19(1):63-68. PubMed ID: 28552935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival.
    Cook AB; Ziazadeh DR; Lu J; Jackson TL
    Math Biosci Eng; 2015 Dec; 12(6):1219-35. PubMed ID: 26775858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the effects of antitumor drugs on cell cycle kinetics.
    Woo KB; Brenkus LB; Wiig KM
    Cancer Chemother Rep; 1975; 59(4):847-60. PubMed ID: 1236772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to cancer chemotherapy.
    Zajicek G
    Med Hypotheses; 1986 Feb; 19(2):103-12. PubMed ID: 3634906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.